Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome-Reference-Cited by-同舟云学术

Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome

Published:2023-11-03 Issue:1 Volume:59 Page:101-106
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Harbi Samia,Brac de la Perriere Louison,Bouchacourt Benjamin^ORCID,Garciaz Sylvain^ORCID,Pagliardini Thomas,Calmels Boris^ORCID,Cecile Maud,Lefloch Anne-Charlotte,Hicheri Yosr,Hospital Marie-Anne,Fürst Sabine,Lemarie Claude,Braticevic Cécile,Legrand Faezeh,Bekrieva Elena,Weiller Pierre-Jean^ORCID,Chabannon Christian^ORCID,Vey Norbert,Blaise Didier^ORCID,Devillier Raynier^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-02134-w.pdf

Reference44 articles.

1. Lin RJ, Artz AS. Allogeneic hematopoietic cell transplantation for older patients. Hematol Am Soc Hematol Educ Program. 2021;2021:254–63.

2. Blaise D, Devillier R, Lecoroller-Sorriano A-G, Boher J-M, Boyer-Chammard A, Tabrizi R, et al. Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial. Haematologica. 2015;100:269–74.

3. Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, et al. Phase II study of allogeneic transplantation for older patients with acute myeloid leukemia in first complete remission using a reduced-intensity conditioning regimen: results from cancer and leukemia group B 100103 (Alliance for Clinical Trials in Oncology)/blood and marrow transplant clinical trial network 0502. J Clin Oncol. 2015;33:4167–75.

4. Ustun C, Le-Rademacher J, Wang H-L, Othus M, Sun Z, Major B, et al. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. Leukemia. 2019;33:2599–609.

5. Versluis J, Hazenberg CLE, Passweg JR, van Putten WLJ, Maertens J, Biemond BJ, et al. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukemia: a time-dependent analysis. Lancet Haematol. 2015;2:e427–36.